OSCR Valuation

Oscar Health Inc

Add to Watchlist

Advanced Chart

16.660

-0.58(-3.364%)1D

Overview
Forecast
Valuation
Earnings

OSCR Relative Valuation

OSCR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, OSCR is overvalued; if below, it's undervalued.

Historical Valuation

Oscar Health Inc (OSCR) is now in the Fair zone, suggesting that its current forward PS ratio of 0.37 is considered Fairly compared with the five-year average of 28.73. The fair price of Oscar Health Inc (OSCR) is between 14.86 to 19.60 according to relative valuation methord.

Relative Value

Fair Zone

14.86-19.60

Current Price：17.22

Fair

-13.98

Trailing

Forward

-17.65

EV/EBITDA

Oscar Health Inc. (OSCR) has a current EV/EBITDA of -17.65. The 5-year average EV/EBITDA is 1.20. The thresholds are as follows: Strongly Undervalued below -15.46, Undervalued between -15.46 and -7.13, Fairly Valued between 9.52 and -7.13, Overvalued between 9.52 and 17.85, and Strongly Overvalued above 17.85. The current Forward EV/EBITDA of -17.65 falls within the Strongly Undervalued range.

-7.56

EV/EBIT

Oscar Health Inc. (OSCR) has a current EV/EBIT of -7.56. The 5-year average EV/EBIT is 4.05. The thresholds are as follows: Strongly Undervalued below -20.73, Undervalued between -20.73 and -8.34, Fairly Valued between 16.44 and -8.34, Overvalued between 16.44 and 28.83, and Strongly Overvalued above 28.83. The current Forward EV/EBIT of -7.56 falls within the Historic Trend Line -Fairly Valued range.

0.37

Oscar Health Inc. (OSCR) has a current PS of 0.37. The 5-year average PS is 0.51. The thresholds are as follows: Strongly Undervalued below -0.54, Undervalued between -0.54 and -0.02, Fairly Valued between 1.03 and -0.02, Overvalued between 1.03 and 1.55, and Strongly Overvalued above 1.55. The current Forward PS of 0.37 falls within the Historic Trend Line -Fairly Valued range.

0.00

P/OCF

Oscar Health Inc. (OSCR) has a current P/OCF of 0.00. The 5-year average P/OCF is -6.88. The thresholds are as follows: Strongly Undervalued below -70.32, Undervalued between -70.32 and -38.60, Fairly Valued between 24.84 and -38.60, Overvalued between 24.84 and 56.56, and Strongly Overvalued above 56.56. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.

-5.31

P/FCF

Oscar Health Inc. (OSCR) has a current P/FCF of -5.31. The 5-year average P/FCF is 4.01. The thresholds are as follows: Strongly Undervalued below -44.19, Undervalued between -44.19 and -20.09, Fairly Valued between 28.11 and -20.09, Overvalued between 28.11 and 52.21, and Strongly Overvalued above 52.21. The current Forward P/FCF of -5.31 falls within the Historic Trend Line -Fairly Valued range.

Oscar Health Inc (OSCR) has a current Price-to-Book (P/B) ratio of 3.84. Compared to its 3-year average P/B ratio of 2.58 , the current P/B ratio is approximately 48.79% higher. Relative to its 5-year average P/B ratio of 2.23, the current P/B ratio is about 72.51% higher. Oscar Health Inc (OSCR) has a Forward Free Cash Flow (FCF) yield of approximately 27.34%. Compared to its 3-year average FCF yield of 13.70%, the current FCF yield is approximately 99.50% lower. Relative to its 5-year average FCF yield of 9.68% , the current FCF yield is about 182.32% lower.

3.84

P/B

Median3y

2.58

Median5y

2.23

27.34

FCF Yield

Median3y

13.70

Median5y

9.68

Competitors Valuation Multiple

The average P/S ratio for OSCR's competitors is 0.38, providing a benchmark for relative valuation. Oscar Health Inc Corp (OSCR) exhibits a P/S ratio of 0.37, which is -1.48% above the industry average. Given its robust revenue growth of 29.04%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Alignment Healthcare Inc

Molina Healthcare Inc

Performance Decomposition

Market capitalization of OSCR decreased by 5.79% over the past 1 year. The primary factor behind the change was an decrease in P/E Change from -5.02 to -24.08.

The secondary factor is the Revenue Growth, contributed 29.04%to the performance.

Overall, the performance of OSCR in the past 1 year is driven by P/E Change. Which is more unsustainable.

29.04%

2.22B → 2.86B

Revenue Growth

-414.17%

2.54 → -7.98

Margin Expansion

379.34%

-5.02 → -24.08

P/E Change

-5.79%